Verena Pichler

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

Nanomaterials (Basel, Switzerland)

RSC advances

University of Vienna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Vienna Oct 01 2017

Austria

Lecturer

Medical University of Vienna May 01 2016

Austria

PostDoc :: Department for Medical Imaging and Image-guided Therapy

Publications

Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger, Boryana Moneva, Katharina Pallitsch, Barbara Lieder, Anna Sophia Zacher, Stefanie Ponti, Katarína Benčurová, Jiaye Yang, Sandra Högler, Petra Kodajova, Lukas Kenner, Marcus Hacker, Wolfgang Wadsak
Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. Journal of medicinal chemistry 67 (5) (2024)
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger, Boryana Moneva, Katharina Pallitsch, Barbara Lieder, Anna Sophia Zacher, Stefanie Ponti, Katarína Benčurová, Jiaye Yang, Sandra Högler, Petra Kodajova, Lukas Kenner, Marcus Hacker, Wolfgang Wadsak
Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. Journal of medicinal chemistry (2024)
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger, Boryana Moneva, Katharina Pallitsch, Barbara Lieder, Anna Sophia Zacher, Stefanie Ponti, Katarína Benčurová, Jiaye Yang, Sandra Högler, Petra Kodajova, Lukas Kenner, Marcus Hacker, Wolfgang Wadsak
Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. Journal of medicinal chemistry 67 (5) (2024)
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger, Boryana Moneva, Katharina Pallitsch, Barbara Lieder, Anna Sophia Zacher, Stefanie Ponti, Katarína Benčurová, Jiaye Yang, Sandra Högler, Petra Kodajova, Lukas Kenner, Marcus Hacker, Wolfgang Wadsak
Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. Journal of medicinal chemistry 67 (5) (2024)
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger, Boryana Moneva, Katharina Pallitsch, Barbara Lieder, Anna Sophia Zacher, Stefanie Ponti, Katarína Benčurová, Jiaye Yang, Sandra Högler, Petra Kodajova, Lukas Kenner, Marcus Hacker, Wolfgang Wadsak
Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. Journal of medicinal chemistry 67 (5) (2024)
Verena Kopatz, Kevin Wen, Tibor Kovács, Alison S Keimowitz, Verena Pichler, Joachim Widder, A Dick Vethaak, Oldamur Hollóczki, Lukas Kenner
Micro- and Nanoplastics Breach the Blood-Brain Barrier (BBB): Biomolecular Corona's Role Revealed. Nanomaterials (Basel, Switzerland) 13 (8) (2023)
Verena Kopatz, Kevin Wen, Tibor Kovács, Alison S Keimowitz, Verena Pichler, Joachim Widder, A Dick Vethaak, Oldamur Hollóczki, Lukas Kenner
Micro- and Nanoplastics Breach the Blood-Brain Barrier (BBB): Biomolecular Corona's Role Revealed. Nanomaterials (Basel, Switzerland) 13 (8) (2023)
Karolina Dzedulionytė, Nina Fuxreiter, Ekaterina Schreiber-Brynzak, Asta Žukauskait, Algirdas Šačkus, Verena Pichler, Eglė Arbačiauskienė
Pyrazole-based lamellarin O analogues: synthesis, biological evaluation and structure-activity relationships. RSC advances 13 (12) (2023)
Verena Kopatz, Kevin Wen, Tibor Kovács, Alison S Keimowitz, Verena Pichler, Joachim Widder, A Dick Vethaak, Oldamur Hollóczki, Lukas Kenner
Micro- and Nanoplastics Breach the Blood-Brain Barrier (BBB): Biomolecular Corona's Role Revealed. Nanomaterials (Basel, Switzerland) 13 (8) (2023)
Karolina Dzedulionytė, Nina Fuxreiter, Ekaterina Schreiber-Brynzak, Asta Žukauskait, Algirdas Šačkus, Verena Pichler, Eglė Arbačiauskienė
Pyrazole-based lamellarin O analogues: synthesis, biological evaluation and structure-activity relationships. RSC advances 13 (12) (2023)
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tina Nehring, Katharina Pallitsch, Barbara Lieder, Marcus Hacker, Wolfgang Wadsak
On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Jonas Kilian, Marlon Millard, Marius Ozenil, Dominik Krause, Khadija Ghaderi, Wolfgang Holzer, Ernst Urban, Helmut Spreitzer, Wolfgang Wadsak, Marcus Hacker, Thierry Langer, Verena Pichler
Synthesis, Biological Evaluation, and Docking Studies of Antagonistic Hydroxylated Arecaidine Esters Targeting mAChRs. Molecules (Basel, Switzerland) 27 (10) (2022)
Jonas Kilian, Marius Ozenil, Marlon Millard, Dorka Fürtös, Verena Maisetschläger, Wolfgang Holzer, Wolfgang Wadsak, Marcus Hacker, Thierry Langer, Verena Pichler
Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M 1 Antagonists. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Sebastian Klug, Godber Mathis Godbersen, Lucas Rischka, Wolfgang Wadsak, Verena Pichler, Manfred Klöbl, Marcus Hacker, Rupert Lanzenberger, Andreas Hahn
Learning induces coordinated neuronal plasticity of metabolic demands and functional brain networks. Communications biology 5 (1) (2022)
Chrysoula Vraka, Matej Murgaš, Lucas Rischka, Barbara Katharina Geist, Rupert Lanzenberger, Gregor Gryglewski, Thomas Zenz, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Cécile Philippe, Verena Pichler
Simultaneous radiomethylation of [ 11 C]harmine and [ 11 C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual. Scientific reports 12 (1) (2022)
Eva-Maria Klebermass, Mahshid Mahmudi, Barbara Katharina Geist, Verena Pichler, Chrysoula Vraka, Theresa Balber, Anne Miller, Arvand Haschemi, Helmut Viernstein, Nataliya Rohr-Udilova, Marcus Hacker, Markus Mitterhauser
If It Works, Don't Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Marius Ozenil, Jonas Aronow, Marlon Millard, Thierry Langer, Wolfgang Wadsak, Marcus Hacker, Verena Pichler
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Raffaella Calabretta, Philipp B Staber, Christoph Kornauth, Xia Lu, Patrick Binder, Verena Pichler, Markus Mitterhauser, Alexander R Haug, Xiang Li, Marcus Hacker
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology 10 (11) (2021)
Marius Ozenil, Jonas Aronow, Daniela Piljak, Chrysoula Vraka, Wolfgang Holzer, Helmut Spreitzer, Wolfgang Wadsak, Marcus Hacker, Verena Pichler
Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)
Chrysoula Vraka, Verena Pichler, Neydher Berroterán-Infante, Tim Wollenweber, Anna Pillinger, Maximilian Hohensinner, Lukas Fetty, Dietrich Beitzke, Xiang Li, Cecile Philippe, Katharina Pallitsch, Markus Mitterhauser, Marcus Hacker, Wolfgang Wadsak
Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)
Verena Pichler, Marius Ozenil, Karsten Bamminger, Chrysoula Vraka, Marcus Hacker, Oliver Langer, Wolfgang Wadsak
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide. EJNMMI radiopharmacy and chemistry 4 (1) (2019)

Verena Pichler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Verena Pichler